Home
Conditions
Urogenital Neoplasms

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,030 public trials 2,565 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Not yet recruiting

IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer

NCT07674615

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations: Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Whole Versus Partial Gland Boost During Prostate SBRT

NCT07574489

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: Fred & Pamela Buffet Cancer Center Omaha, Nebraska, United States

View Trial Details

Not yet recruiting

PROLONG (PRostateOLaparibONcombinationGcc) Study

NCT07674121

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

NCT07545460

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Yunnan Cancer Hospital Kunming, Yunnan, China

View Trial Details

Not yet recruiting

Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer

NCT07673211

Conditions: Cervical Cancer, Disease Attributes, Disease Progression, +18 more
Locations: Not specified

View Trial Details

Not yet recruiting

Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva

NCT07672782

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +22 more
Locations: Atrium Health Levine Cancer Center Charlotte, North Carolina, United States

View Trial Details

Not yet recruiting

Iparomlimab and Tuvonralimab Plus Chemotherapy as Neoadjuvant Therapy for Ovarian Cancer（Phase II）

NCT07673835

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Obstetrics and Gynecology Hospital of Fudan University Shanghai, China

View Trial Details

Not yet recruiting

Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy

NCT07670962

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Not specified

View Trial Details

Not yet recruiting

COQ10 and Vitamin E for Off-Target Radiation Toxicity

NCT07668284

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +30 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Not yet recruiting

A Study of DAT-2645 in Patients With BRCA1/2 Mutations or HRD-Positive Ovarian Cancer

NCT07652073

Conditions: Adnexal Diseases, Advanced or Metastatic Ovarian Cancer, Endocrine Gland Neoplasms, +13 more
Locations: Research site Guangzhou, Guangdong, China

Research site Beijing, China

View Trial Details

Urogenital Neoplasms

Urogenital Neoplasms trial results

Related conditions